´óÏó´«Ã½

´óÏó´«Ã½'s Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.

´óÏó´«Ã½ researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.

´óÏó´«Ã½ neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.

Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.

´óÏó´«Ã½ has added a new state-of-the-art MRI system to its research infrastructure, marking a transformative step forward for groundbreaking studies in neuroscience, clinical health and medical advancements.

A groundbreaking study by ´óÏó´«Ã½ researchers using a tiny roundworm, links the worm gene swip-10 to copper regulation, which could pave the way for new treatments for neurodegenerative disorders.

´óÏó´«Ã½ has been ranked No. 41 overall among the nation's best public and private universities by Washington Monthly.

With the help of a tiny, transparent worm, ´óÏó´«Ã½ researchers have identified novel players in dopamine signaling by taking advantage of a powerful platform generated via the Million Mutation Project (MMP).

"Fit2Drive," an algorithm developed by ´óÏó´«Ã½ researchers has made it easy to administer and evaluate an in-office test to predict an older individual's probability of passing an on-road driving test.

The summit brought together leading scientists in the field across North America and Europe to discuss the latest research and advancements in the study of amyloid-related diseases.